Skip to main content

Table 1 Data distribution and statistical analysis

From: The effect of the pro-inflammatory cytokine tumor necrosis factor-alpha on human joint capsule myofibroblasts

   

Fold change of the respective patient sample in the control group (log2)

 

Experiment

Group

Numbera

25th quartile

Median

75th quartile

P value

MTT assay

B: 1 ng/mL TNF-α

36

0.37

0.60

0.85

B vs. A: <0.001

 

C: 10 ng/mL TNF-α

68

0.43

0.60

0.85

C vs. A: <0.001

 

D: 1 ng/mL TNF-α + 10 μg/mL IFX

36

-0.03

0.13

0.39

D vs. B: <0.001

 

E: 10 ng/mL TNF-α + 10 μg/mL IFX

36

0.21

0.38

0.78

E vs. C: <0.001

 

F: 10 μg/mL IFX

36

-0.21

0.02

0.30

F vs. A: 0.2

 

G: 10 ng/mL TNF-α + 10 μg/mL Diclo

28

0.02

0.16

0.30

G vs. C: 0.031

3D collagen gel

B: 1 ng/mL TNF-α

40

-0.01

0.23

0.46

B vs. A: <0.001

 

C: 10 ng/mL TNF-α

52

0.71

0.90

1.47

C vs. A: <0.001

 

D: 1 ng/mL TNF-α + 10 μg/mL IFX

40

-0.44

-0.22

0.04

D vs. B: <0.001

 

E: 10 ng/mL TNF-α + 10 μg/mL IFX

40

-0.35

-0.14

0.19

E vs. C: <0.001

 

F: 10 μg/mL IFX

40

-0.23

-0.01

0.15

F vs. A: 0.6

 

G: 10 ng/mL TNF-α + 10 μg/mL Diclo

40

0.04

0.17

0.67

G vs. C: 0.002

qPCR

      

α-SMA

B: 1 ng/mL TNF-α

8

-1.01

-0.14

1.15

B vs. A: 0.8

 

C: 10 ng/mL TNF-α

25

-6.29

-5.64

-3.48

C vs. A: <0.001

 

D: 1 ng/mL TNF-α + 10 μg/mL IFX

8

-1.20

-0.004

0.90

D vs. B: 0.4

 

E: 10 ng/mL TNF-α + 10 μg/mL IFX

8

-0.63

-0.50

0.10

E vs. C: 0.01

 

F: 10 μg/mL IFX

8

-0.45

-0.32

-0.12

F vs. A: 0.5

 

G: 10 ng/mL TNF-α + 10 μg/mL Diclo

9

-4.85

-4.32

-3.74

G vs. C: 0.015

Collagen type I

B: 1 ng/mL TNF-α

8

-0.36

-0.007

0.59

B vs. A: 1.0

 

C: 10 ng/mL TNF-α

17

-4.35

-3.47

-3.00

C vs. A: 0.01

 

D: 1 ng/mL TNF-α + 10 μg/mL IFX

8

-0.93

-0.30

0.54

D vs. B: 0.2

 

E: 10 ng/mL TNF-α + 10 μg/mL IFX

8

-1.03

-0.20

0.50

E vs. C: 0.01

 

F: 10 μg/mL IFX

8

-1.60

-0.009

0.27

F vs. A: 0.6

 

G: 10 ng/mL TNF-α + 10 μg/mL Diclo

9

-2.21

-1.84

-0.93

G vs. C: 0.015

  1. aNumber of measurements. 3D, three-dimensional; α-SMA, alpha-smooth muscle actin; Diclo, Diclofenac; IFX, infliximab; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; qPCR, quantitative polymerase chain reaction; TNF-α, tumor necrosis factor-alpha.